HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of International Conference on Tissue Engineering and Regenerative Medicine

September 28-30 | London, UK

September 28 -30, 2026 | London, UK

Megakaryocytes

Megakaryocytes

Megakaryocytes are large, specialized cells found in the bone marrow, responsible for the production of platelets, essential components involved in blood clotting and coagulation. These unique cells undergo a process called thrombopoiesis, where they give rise to platelets through fragmentation of their cytoplasm. Megakaryocytes are characterized by their large size, multilobulated nuclei, and abundant cytoplasmic granules. The regulation of megakaryocyte development and platelet production is tightly controlled by various growth factors, including thrombopoietin. As megakaryocytes mature, they extend long cytoplasmic projections, known as proplatelets, into the bone marrow sinusoids, facilitating the release of platelets into the bloodstream. The intricate balance between megakaryocyte proliferation and platelet release is crucial for maintaining proper hemostasis and preventing excessive bleeding or clotting disorders. Dysregulation of megakaryocyte function is implicated in various hematological conditions, such as thrombocytopenia or myeloproliferative disorders. Understanding the biology of megakaryocytes is vital for deciphering the mechanisms governing platelet production and thrombopoiesis. Ongoing research in hematology aims to uncover the molecular pathways involved in megakaryocyte maturation and platelet release, paving the way for potential therapeutic interventions in bleeding and clotting disorders.

Committee Members
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Nagy Habib

Nagy Habib

Imperial College London, United Kingdom
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Lucie Bacakova

Lucie Bacakova

Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Marco Polettini

Marco Polettini

DVM, Italy

Submit your abstract Today

Youtube
Watsapp